Their finding reaffirmed that AGXT as a new HCC biomarker, and backed up the feasibility and necessity of systematic review on discovering new and reliable biomarkers for HCC as well as for other cancer. The gene discussed is AGXT; the disease is hepatocellular carcinoma.